MRVI: Multiplikator P/S Maravai LifeSciences Corp

Tandha merek Maravai LifeSciences Holdings (MRVI)

Maravai LifeSciences (MRVI) is reducing its reliance on mRNA products by expanding its bioanalysis portfolio, a shift reflected in the P/S ratio dynamics. This chart on GURU.Markets provides data where the 5.30 level reflects the current value. Automated CleanCap lines are driving margin growth, while the implementation of eco-friendly solvents minimizes production toxicity in compliance with green chemistry principles.

MRVI: Multiplikator P/S Maravai LifeSciences 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Maravai (MRVI)

Analisis umum perusahaan:MRVI, Maravai LifeSciences Corp
Sampel barang Maravai LifeSciences Corp

Maravai LifeSciences' status as a key supplier of high-margin components for mRNA therapies makes the revenue multiple a defining indicator of market confidence in the business's growth rates. This chart reflects the price-to-sales ratio through the lens of statistical deviation, where a move beyond two standard deviations signals potential undervaluation or the risk of a deep price correction.

Karo sapa Maravai LifeSciences saingan

Rasio rega marang pendapatan A (Agilent)|Multiplikator P/S DGX (questdiagnostics.com)|Illumina Platform - Rasio rega marang pendapatan|Exact Sciences Inc. - Multiplikator P/S|RVTY: Rasio rega marang pendapatan|Bio-Rad (BIO) - Rasio rega marang pendapatan|NNNN - Koefisien rega marang pendapatan|SHC (Sotera Health Corp) - Multiplikator P/S|Rega marang dodolan QuidelOrtho Inc. QDEL|Multiplikator P/S OPK|CareDx - Rasio kapitalisasi marang pendapatan|Fulgent Genetics, Inc. - Kapitalisasi marang pendapatan|LAB: Rasio kapitalisasi marang pendapatan|Cytek Corp - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan OSUR (OraSure Technologies)|XGN: Multiplikator P/S|MDxHealth - Rasio kapitalisasi pasar marang pendapatan|LUCD (luciddx.com) - Multiplikator P/S|PRE - Multiplikator rega marang pendapatan|Rasio rega marang pendapatan Insight Molecular Diagnostics Inc (IMDX)|TRIB - Rega marang dodolan|Multiplikator P/S PRPH (ProPhase Labs, Inc.)|Koefisien rega marang pendapatan ainos.com (AIMD)|Co-Diagnostics Inc - Multiplikator P/S|HSCS - Multiplikator P/S|BMRA (Biomerica Inc) - Kapitalisasi marang pendapatan|CDIO - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Onconetix Inc|VRAX - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan BJDX (Bluejay Diagnostics)|Multiplikator P/S Aspira Women's Health, Inc. (AWH)|Rasio rega marang pendapatan acceleratediagnostics.com AXDX|Kapitalisasi marang volume dodolan CNTG (centogene.com)|ENZ - Rasio rega marang pendapatan|FRES - Multiplikator P/S|GENE: Multiplikator P/S|Kapitalisasi marang pendapatan 23andMe|PMD (Psychemedics Corp.) - Multiplikator P/S